Last Updated: 01/02/2017 01:27:30
JBFCF Stock Chart - 1 Month
JBFCF Stock Chart - 3 Month
JBFCF Stock Chart - 6 Month
JBFCF Stock Chart - 1 Year
JBFCF Stock Chart - 2 Year
Nostalgia often carries us back to simpler times, whether it's building blanket forts or putting on living room plays. Today, these memories are stirring up a movement, and Celebree School is at the heart of the whirlwind. They're rolling out a campaign aptly titled "Boredom Is Where Imagination Begins," aimed at reintroducing children to creativity beyond screens and...
Continue Reading
Sparks Fly Over Pleasants Power Just when you think you’ve seen every trick in the playbook, along comes another tussle worth its weight in megawatts. Omnis Energy, under its formal name Omnis Pleasants, finds itself in a fiery battle with creditors as the Chapter 11 proceedings heat up over the Pleasants Power Station. With six objections filed ahead of a crucial court...
Continue Reading
Hold onto your hats, folks, because the American Diabetes Association (ADA) just dropped a bombshell report with findings that'll make your head spin if you're keyed into the healthcare sector. They’ve wrapped this up in a bow of accountability, but let's dig into the crux of it. Behind the Controversy: The New Orleans Incident This all harks back to an incident on June...
Continue Reading
Medtronic's Impressive Q1 2027: A Closer Look It's not every day you see a healthcare titan like Medtronic (NYSE: MDT) flex some serious muscle on the financial front. As the first quarter of fiscal year 2027 wrapped up, Medtronic delivered a knockout with a reported 13.7% increase in revenue, totaling a hefty $9.8 billion. This wasn't just luck—this was strategic...
Continue Reading
Nauticus Robotics Hits New Stride with ROV Deployments Some days, you're paddling like hell to stay afloat in this market. But for Nauticus Robotics, marking progress amidst turbulent waters, their recent announcement feels like catching a favorable current. Both of Nauticus’ Comanche ROV systems have been deployed for commercial projects, enhancing their third quarter...
Continue Reading
Panoplai's Meteoric Rise in the AI Landscape There's nothing quite like seeing a company break through the noise with numbers that can make even the most jaded investor sit up straight. Panoplai, an AI-powered insights platform, has done just that, snagging a spot at No. 320 on the 2026 Inc. 5000 list of America's fastest-growing private companies with an eye-popping...
Continue Reading
A Closer Look at Claroty's Forrester Acclaim The waves of cybersecurity analysis have peeled back again, revealing a shining star—Claroty. The latest third-party evaluations seem to show that this beast of a company isn't just cruising; it's tearing up the operational technology security landscape. Named as both a 'Leader' and a 'Customer Favorite' in The Forrester...
Continue Reading
Eyeing Profit in Tenant Liability Insurance CIC Services has cooked up something intriguing for property owners: a shot at fatter profits through their PortfolioVantage program. Launching now, this tenant legal liability strategy promises more than just basic tenant coverage—it's a potential financial boon for savvy landlords willing to dive in. The Gist of...
Continue Reading
The Reverie of Real Imagery It might be time to give New York a spot on your calendar. Adagio, the latest exhibition at Leica Gallery, reveals the enduring magic of Steve McCurry's lens. Running from September 10th to October 18th, 2026, this event does more than showcase photos—it crafts an experience of human connection. A Dance with History This isn’t just a walk...
Continue Reading
MiniMed's Bold Initial Move for Fiscal Year 2027 Ah, MiniMed's come out swinging to kick off FY27, and it’s about time somebody did something right. With net sales clocking in at $843 million, marking a 17% spike as reported and 16% organic growth, you'd think we’d be talking about a tech startup, not a diabetes tech stalwart. These folks have been around for ages,...
Continue Reading
Amgen's Rocatinlimab Trials: An Overview Recently, Amgen Inc (NASDAQ: AMGN) provided an investor update that highlighted promising results from Phase 3 trials of rocatinlimab, a treatment for atopic dermatitis, more commonly known as eczema. This trial included 726 participants and focused on the drug's ability to alleviate the severity and extent of the condition....
Continue Reading
Introducing the TerraMaster D4-320U: A New Era in Storage TerraMaster, renowned for its innovative storage solutions, proudly unveils the D4-320U, a compact 1U 4-bay direct-attached storage (DAS) enclosure. Designed specifically for small offices, home users, and IT environments, this cutting-edge device combines a space-saving rackmount design with an impressive 88TB...
Continue Reading
Cohen & Steers Income Opportunities REIT's Strategic Expansion Cohen & Steers Income Opportunities REIT, Inc. (CNSREIT) has recently made a significant addition to its real estate portfolio. The company announced the acquisition of Bridgepointe Shopping Center, a well-positioned open-air community shopping center. This strategic move was achieved through a programmatic...
Continue Reading
Introducing the Miral Impact Fund Miral has taken a significant step towards environmental stewardship and social responsibility by launching the Miral Impact Fund. This initiative, launched in partnership with the Authority of Social Contribution – Ma'an, aims to create a positive impact within communities by addressing pressing social issues while promoting...
Continue Reading
Key Insights on the Evenflo Booster Seat Settlement Consumers who purchased Evenflo "Big Kid" booster seats may find some relief through a recent class action settlement. The settlement, valued at $3.5 million, addresses allegations that Evenflo Co., Inc. misrepresented the safety and testing of these booster seats. Designed for children over 30 pounds, these seats were...
Continue Reading